title: Increased tracheal responsiveness to beta-adrenergic agonist and antagonist in ovalbumin-sensitized guinea pigs.
abstract: Despite the controversy of bronchial responsiveness to beta2-agonist drugs in asthma, in a previous study we have shown increased responsiveness of asthmatic tracheobronchial tree to isoprenaline. Therefore, in the present study, tracheal responsiveness to isoprenaline and also beta-adrenergic receptor blockade were studied in sensitized guinea pigs. An experimental model of asthma was induced in guinea pigs by sensitization of animals with injection and inhalation of ovalbumin (OA). The responses of tracheal chains of sensitized and control animals to cumulative concentrations of isoprenaline (I) in the absence and presence of 10 nmol/l propranolol were measured, and the effective concentration of I causing 50% of maximum response (EC50 I) was obtained. The propranolol blockade (CR - 1) was calculated by: (post-propranolol EC50 I/EC50 I) - 1. Tracheal responses of sensitized and control animals to cumulative concentrations of methacholine (M) were also measured and EC50 M were obtained. The tracheal responses of sensitized guinea pig to isoprenaline was significantly higher than that of the control animals (EC50 I for sensitized and control animals were 0.24 +/- 0.04 and 0.58 +/- 0.07 micromol/l, respectively; p < 0.001). The beta-adrenergic receptor blockade by propranolol (CR - 1) was also significantly higher in sensitized guinea pigs than that of the control animals (p < 0.001). The results of this study indicate an increased tracheal response to beta-adrenergic-stimulating drug and enhancement of beta-adrenergic blockade by propranolol in the sensitized guinea pig.
authors.affiliation: Department of Physiology, Ghaem Medical Center, Mashhad University of Medical Sciences, Iran. m-boskabady@mums.ac.ir
authors.forename: M H
authors.initials: MH
authors.lastname: Boskabady
authors.forename: A
authors.initials: A
authors.lastname: Zarei
mesh_terms: D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000336:Aerosols; D000818:Animals; D016535:Bronchial Hyperreactivity / Q000139:chemically induced / Q000276:immunology* / Q000503:physiopathology; D004195:Disease Models, Animal; D006168:Guinea Pigs / Q000276:immunology*; D007114:Immunization / Q000379:methods; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007545:Isoproterenol / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology; D008297:Male; D016210:Methacholine Chloride / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology*; D011433:Propranolol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014132:Trachea / Q000187:drug effects / Q000276:immunology* / Q000503:physiopathology
chemical_list: D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000336:Aerosols; D016210:Methacholine Chloride; D010047:Ovalbumin; D011433:Propranolol; D007545:Isoproterenol